Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: February 2, 2023

Drugs in MeSH Category Cholinesterase Inhibitors

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	GALANTAMINE HYDROBROMIDE	galantamine hydrobromide	CAPSULE, EXTENDED RELEASE;ORAL	090900-002	Jan 24, 2011		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Barr	GALANTAMINE HYDROBROMIDE	galantamine hydrobromide	CAPSULE, EXTENDED RELEASE;ORAL	078189-002	Sep 15, 2008	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Bausch	MESTINON	pyridostigmine bromide	TABLET, EXTENDED RELEASE;ORAL	011665-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Fera Pharms Llc	PHOSPHOLINE IODIDE	echothiophate iodide	FOR SOLUTION;OPHTHALMIC	011963-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Sandoz	GALANTAMINE HYDROBROMIDE	galantamine hydrobromide	TABLET;ORAL	077589-002	Jun 22, 2009	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa Inc	GALANTAMINE HYDROBROMIDE	galantamine hydrobromide	TABLET;ORAL	078898-001	Feb 17, 2011	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Breckenridge	RIVASTIGMINE	rivastigmine	FILM, EXTENDED RELEASE;TRANSDERMAL	209063-003	Nov 26, 2019	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Colorcon

AstraZeneca

Harvard Business School

Express Scripts

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.